Viking's chief executive, Brian Lin, said that "the progressive nature of the weight loss curves suggests the potential for further improvement with longer dosing periods," suggesting that VK2375 could still mount a challenge to rival oral therapies, which have been tested over longer periods of a year or more
Beyond the mild, commonly reported effects, several theoretical risks deserve serious attention precisely because they have not been ruled out by human research
Key Takeaways The 60mg pen consolidates a full 2.515mg escalation sequence into one device, eliminating mid-protocol pen swaps and associated lot-number variables
20 CT All skin types
Bacterial Growth Studies have shown that bacteria are present on the needle after injection and that bacterial growth increases when the needle is further re-used
Cipriani A, Furukawa TA, Salanti G, Chaimani A, Atkinson LZ, Ogawa Y, et al